"Istituto Ortopedico"

During the past decade, Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" are "Ewing Sarcoma of Bone" (1 trials) and "Osteofibrous Dysplasia" (1 trials). Many other conditions were trialed in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" in a lesser frequency.

Most popular intervention types in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" are "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Scoring tool in Chemotherapy-induced necrosis in Ewing sarcoma" (1 trials) and "study of osteofibrous dysplasia features" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".